Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Therapeutic Advances in Medical Oncology|December 17, 2019
Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolizationHsin-Lun Lee, Jo-Ting Tsai, Chun-You Chen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 20, 2026
Multicenter validation and randomized crossover reader evaluation of deep learning-assisted tri-sequence three-dimensional MRI segmentation for hypopharyngeal tumorCheyu Hsu, He-Lin Ku, Shih-Min Lin, et al.Acta Cardiologica Sinica|January 24, 2022
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)Long-Sheng Lu, Yen-Wen Wu, Joseph Tung-Chieh Chang, et al.American Journal of Respiratory and Critical Care Medicine|October 2, 2012
Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancerChi-Tai Yeh, Alexander T H Wu, Peter M-H Chang, et al.European Journal of Cancer (Oxford, England : 1990)|March 20, 2022
Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinomaYuan-Hung Wu, Yi-Ping Hung, Nai-Chi Chiu, et al.Journal of Personalized Medicine|April 28, 2023
Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with SarcomaJia-Hui Huang, Shu-Huey Chen, Yu-Mei Liao, et al.Vaccines|February 26, 2022
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in TaiwanJer-Hwa Chang, Jeng-Fong Chiou, Ching-Sheng Hung, et al.Neurology|June 1, 2026
Identification of Novel Genetic Risk Variants Associated With Early-Onset Ischemic Stroke in TaiwanYin-Cheng Wang, Kai-Ming Liu, Yu-Ling Gan, et al.Cancer Letters|July 12, 2025
Deglycosylated PD-L1 is a biomarker for immune checkpoint blockade response: a real-world study in breast cancer patients in TaiwanShao-Chun Wang, Yi-Chun Shen, Mei-Ren Pan, et al.Nature|October 15, 2025
Population-specific polygenic risk scores for people of Han Chinese ancestryHung-Hsin Chen, Chien-Hsiun Chen, Ming-Chih Hou, et al.Pageof 12